BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC
· Real-Time Price · USD
5.41
-0.16 (-2.87%)
At close: Aug 14, 2025, 3:58 PM
5.32
-1.66%
Pre-market: Aug 15, 2025, 09:04 AM EDT
BioNexus Gene Lab Fail-to-Deliver
Total FTD Shares
18.62K
Below Average
FTD / Avg. Volume
0.90%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
BioNexus Gene Lab Corp. has
18,618
shares failed to deliver, representing 0.90%
of the average daily volume of
2,058,470
shares. Over the past year, the monthly average FTD is
28,764
shares, with the current level 35% below
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 3.97 | 18.62K | +1784.41% |
| Jun 10, 2025 | 3.14 | 988 | -68.25% |
| May 30, 2025 | 4.29 | 3.11K | +3889.74% |
| Apr 30, 2025 | 2.85 | 78 | -99.92% |
| Mar 31, 2025 | 2.36 | 94.63K | +13673.94% |
| Feb 27, 2025 | 3.35 | 687 | -69.05% |
| Jan 31, 2025 | 4.07 | 2.22K | -96.37% |
| Dec 24, 2024 | 2.43 | 61.18K | +6246.89% |
| Nov 26, 2024 | 2.44 | 964 | -89.62% |
| Oct 31, 2024 | 3.6 | 9.29K | -62.83% |
| Sep 27, 2024 | 4.44 | 24.99K | +24.05% |
| Aug 28, 2024 | 4.58 | 20.14K | +11216.29% |
| Jul 31, 2024 | 4.88 | 178 | -93.77% |
| Jun 27, 2024 | 4.61 | 2.86K | -19.38% |
| May 30, 2024 | 4.36 | 3.54K | +406.43% |
| Apr 25, 2024 | 5.93 | 700 | +4566.67% |
| Mar 22, 2024 | 7.25 | 15 | -99.81% |
| Feb 27, 2024 | 7.1 | 7.93K | +5261.49% |
| Jan 30, 2024 | 4.75 | 148 | -97.95% |
| Dec 29, 2023 | 5.3 | 7.24K | -98.18% |
| Nov 30, 2023 | 9.5 | 397.82K | +11518.66% |
| Oct 31, 2023 | 4.19 | 3.42K | +68380.00% |
| Sep 29, 2023 | 8.7 | 5 | -99.37% |
| Aug 10, 2023 | 11.4 | 789 | -97.40% |
| Jul 31, 2023 | 22.3 | 30.37K | +1429.77% |
| Jun 27, 2023 | 0.45 | 1.99K | +499.70% |
| May 31, 2023 | 34.5 | 331 | n/a |